Journal of Diabetes and Its Complications
Volume 23, Issue 3 , Pages 194-198, May 2009

Iron status in women with and without gestational diabetes mellitus

Diabetes Research Center, Shahid Sadoughi University of Medical Science and Health Services, Yazd, Iran

Received 14 June 2007; received in revised form 6 September 2007; accepted 9 November 2007. published online 14 March 2008.

Abstract 

Objective

Gestational diabetes mellitus (GDM) affects approximately 7% of all pregnancies. Pregnancy, mostly because of the mitochondria-rich placenta, is a condition that favors oxidative stress. A transitional metal, especially iron, which is particularly abundant in the placenta, is important in the production of free radicals. Also, studies have shown that free radicals have a role in GDM. As there are little data about iron status in GDM, this study was performed to compare iron status in GDM and control group.

Research Design and Methods

In this case-control study, 34 women with diagnosed GDM were compared with 34 non-GDM women in the control group at 24–28 weeks of pregnancy in terms of iron status, including ferritin, serum iron, total iron-binding capacity (TIBC), hemoglobin (Hb), mean corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH).

Results

In this study, concentration of serum ferritin, iron, transferrin saturation and hemoglobin, MCV, and MCH was significantly higher in the GDM group and TIBC was significantly lower in this group (P<.05). No significant association was observed with the other variables including familial history of diabetes and GDM.

Conclusion

Our findings indicate an association between increased iron status and GDM. The role of iron excess from iron supplementation in the pathogenesis of GDM needs to be examined.

Keywords: Gestational diabetes mellitus, Serum ferritin, Serum iron

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflict of interest: Dr. Mohammad Afkhami-Ardekani serves as a director of Yazd Diabetes Research Center and Dr. Maryam Rashidi is an employee of Yazd Diabetes Research Center.

PII: S1056-8727(07)00140-7

doi:10.1016/j.jdiacomp.2007.11.006

Journal of Diabetes and Its Complications
Volume 23, Issue 3 , Pages 194-198, May 2009